Internal Medicine 1411 - Internal Medicine Alert - Jun 15, 2010

Target Audience:

This activity is intended for the internist and family practitioner.

Accreditation:

AHC Media is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Credit Designation:

AHC Media designates this enduring material for a maximum of 1.75 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
 
Internal Medicine Alert has been reviewed and is acceptable for up to 1 Prescribed credit by the American Academy of Family Physicians. AAFP accreditation begins 01/01/10. Term of approval is for one year from this date. Credit may be claimed for 1 year from the date of each issue.

Faculty

Executive Editor
Stephen A. Brunton, MD

Clinical Professor
University of California, Irvine

Associate Editors
Mary Elina Ferris, MD
Clinical Associate Professor
University of Southern California

Barbara A. Phillips, MD, MSPH

Professor of Medicine, University of Kentucky;
Director, Sleep Disorders Center
Samaritan Hospital, Lexington

William T. Elliott, MD, FACP
Chair, Formulary Committee
Northern California Kaiser Permanente
Asst. Clinical Professor of Medicine
University of California
San Francisco

James Chan, PharmD, PhD
Pharmacy Quality and Outcomes Manager
Kaiser Permanente
Oakland, CA

Louis Kuritzky, MD
Clinical Assistant Professor
University of Florida
Gainesville

Ken Grauer, MD
Professor, Assistant Director
Family Practice Residency
Program, University of Florida

Peer reviewer
Gerald Roberts, MD
Assistant Clinical Professor of Medicine
Albert Einstein College of Medicine
New York, NY

Subjects:

  • PPI Use and Fracture Risk
  • Monofilament Testing for Diabetic Peripheral Neuropathy
  • Osteoporosis Treatment After Hip Fracture: Missed Opportunities
  • Sipuleucel-T Suspension for Intravenous Infusion (Provenge┬«)
  • Clinical Briefs By Louis Kuritzky, MD
  • ECG Review RBBB Plus?

Objectives:

  • describe new findings in differential diagnosis and treatment of various diseases
  • describe controversies, advantages, and disadvantages of those advances
  • describe cost-effective treatment regimens
  • describe the pros and cons of new screening procedures.

Financial Disclosure:

Internal Medicine Alert’s editor, Stephen Brunton, MD, is a consultant for Amylin, Cephalon, Novo Nordisk, Sciele, and Takeda; he receives grant/research support and serves on the speakers bureau of Cephalon and Novo Nordisk. Associate editors Mary Elina Ferris, MD, William T. Elliott, MD, FACP, James Chan, PharmD, PhD, and peer reviewer Gerald Roberts, MD, report no financial relationship to this field of study.Louis Kuritzky, MD is a consultant for GlaxoSmithKline and is on the speaker's bureau of GlaxoSmithKline, 3M, Wyeth-Ayerst, Pfizer, Novartis, Bristol-Myers Squibb, AstraZeneca, Jones Pharma, and Boehringer Ingelheim. Associate editor Ken Grauer, MD is the sole proprietor of KG-EKG Press, and publisher of an ECG pocket brain book. Associate editor Barbara A. Phillips, MD, MSPH is a consultant for Cephalon, and serves on the speakers bureaus for Resmed and Respironics.

Copyright 2010 AHC Media. All rights reserved.